Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Synthetic peptides as vaccines.

R Arnon¹, R J Horwitz

¹Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel.

Current Opinion in Immunology

|August 1, 1992

Summary

Synthetic peptides offer a promising alternative for developing vaccines against challenging viral and parasitic diseases. This approach is crucial for conditions like acquired immune deficiency syndrome where traditional vaccines are unavailable.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[50] Reaction with N-carboxy-α-amino acid anhydrides.

Methods in enzymology·2012

Same author

Anti-lymphocyte therapy successfully controls late "cholestatic" rejection in pediatric liver transplant recipients.

Clinical transplantation·2011

Same author

Stevens-Johnson syndrome after Mycoplasma pneumonia infection in pediatric post-liver transplant recipient: case report and review of the literature.

Pediatric transplantation·2010

Same author

Glatiramer acetate (GA, Copolymer-1) an hypothetical treatment option for Rett syndrome.

Medical hypotheses·2010

Same author

A universal epitope-based influenza vaccine and its efficacy against H5N1.

Vaccine·2009

Same author

Antibodies to glatiramer acetate do not interfere with its biological functions and therapeutic efficacy.

Multiple sclerosis (Houndmills, Basingstoke, England)·2003

Area of Science:

Immunology
Vaccinology
Synthetic Biology

Background:

Traditional vaccine development faces challenges for certain infectious diseases.
Viral and parasitic infections, including acquired immune deficiency syndrome (AIDS), lack effective vaccines.
Synthetic peptides are being explored as a novel vaccination strategy.

Purpose of the Study:

To investigate the potential of synthetic peptides as an alternative vaccination approach.
To address the unmet need for vaccines against specific viral and parasitic diseases.

Main Methods:

Utilizing synthetic peptide technology for vaccine design.
Evaluating the immunogenicity and efficacy of peptide-based vaccines (details not provided in abstract).

Main Results:

Synthetic peptides are a viable alternative for vaccine development (details not provided in abstract).
This approach shows promise for diseases currently lacking vaccines.

Conclusions:

Synthetic peptide-based vaccination represents a significant advancement in vaccinology.
Further research is warranted to develop peptide vaccines for diseases like AIDS.

Related Experiment Videos